Knight Therapeutics Inc opened trading today at $5.48 and closed at $5.57. It traded at a low of $5.48 to a high of $5.65.

Share prices boosted 0.54% from the previous day's close of $5.54.

During the day across North America, the TSX Composite closed -0.02% at 22260.30, the S&P 500 closed -0.04% at 5202.39, the Dow Jones Industrial Average closed -0.03% at 38892.80 and the Nasdaq Composite closed 0.03% at 16253.96.

Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).

Trading volume was 62,751 on 379 total trades, with an average volume of 56,394 in the last five days.

The TSX market on the whole today saw 2,909 price advancers against 2,322 declines and 125 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.75 (January 22,2024) and low as $4.35 (October 23,2023). Moreover, in the last 52 weeks, Knight Therapeutics Inc's shares have boosted 20.30%, while they have advanced 7.32% this year.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $560.48 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Knight Therapeutics Inc's average recommendation is "Moderate Buy" based on 4.00 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..